---
figid: PMC6540009__ijms-20-02314-g006
figtitle: Scheme of the effect of pioglitazone on CKD-mediated ER stress in CKD-MSCs
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Mus musculus
- Cricetus cricetus
- Homo sapiens
- Armoracia rusticana
- prion
organisms_ner:
- Homo sapiens
- Mus musculus
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Drosophila melanogaster
pmcid: PMC6540009
filename: ijms-20-02314-g006.jpg
figlink: /pmc/articles/PMC6540009/figure/ijms-20-02314-f006/
number: F6
caption: Scheme of the effect of pioglitazone on CKD-mediated ER stress in CKD-MSCs.
  CKD pathophysiological condition induces ER stress, ROS generation, and mitochondrial
  dysfunction, leading to reduction of cell proliferation in CKD-MSCs. However, treatment
  of CKD-MSCs with pioglitazone increases the activation of the PGC-1α-PrPC signal
  pathway, resulting in protection of mitochondrial function and cell proliferation
  against CKD-induced ER stress. Black arrow means cell signal pathway. Red arrow
  means down-regulation of protein activation or expression. Blue arrow means up-regulation
  of protein activation or expression.
papertitle: Pioglitazone Improves the Function of Human Mesenchymal Stem Cells in
  Chronic Kidney Disease Patients.
reftext: Yeo Min Yoon, et al. Int J Mol Sci. 2019 May;20(9):2314.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.933542
figid_alias: PMC6540009__F6
figtype: Figure
redirect_from: /figures/PMC6540009__F6
ndex: 6d58e1f8-dec0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6540009__ijms-20-02314-g006.html
  '@type': Dataset
  description: Scheme of the effect of pioglitazone on CKD-mediated ER stress in CKD-MSCs.
    CKD pathophysiological condition induces ER stress, ROS generation, and mitochondrial
    dysfunction, leading to reduction of cell proliferation in CKD-MSCs. However,
    treatment of CKD-MSCs with pioglitazone increases the activation of the PGC-1α-PrPC
    signal pathway, resulting in protection of mitochondrial function and cell proliferation
    against CKD-induced ER stress. Black arrow means cell signal pathway. Red arrow
    means down-regulation of protein activation or expression. Blue arrow means up-regulation
    of protein activation or expression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PPARGC1A
  - EIF2A
  - EIF2S1
  - EIF2AK3
  - ATF4
  - ERN1
  - MAPK8
  - MAPK9
  - MAPK10
  - DDIT3
  - SOD1
  - SOD2
  - SOD3
  - CRMP1
  - UTRN
  - DENR
  - DNM1L
  - DAPK2
  - MFN1
  - OPA1
  - MED12
  - MSC
  - SLC25A37
  - PRNP
  - ST13
  - STIP1
  - HOPX
  - CARD16
  - Ppargc1a
  - Eif2a
  - Eif2s1
  - Eif2ak3
  - Lamp1
  - Atf4
  - Ern1
  - Mapk8
  - Ddit3
  - Crmp1
  - Dnm1l
  - Mfn1
  - Opa1
  - Med12
  - Msc
  - Prnp
  - Stip1
  - St13
  - Hopx
  - Ift56
  - srl
  - eIF2alpha
  - PEK
  - rl
  - crc
  - Ire1
  - bsk
  - Cat
  - so
  - Sod2
  - Sod1
  - Drp1
  - fzo
  - msc
  - Scr
  - op
  - hop
  - cop
  - Yif1
  - Pioglitazone
  - Chronic Kidney Disease
---
